Extremophilic polysaccharide nanoparticles for cancer nanotherapy and evaluation of antioxidant properties

S. Raveendran, V. Palaninathan, Y. Nagaoka, T. Fukuda, S. Iwai, T. Higashi, T. Mizuki, Y. Sakamoto, P.V. Mohanan, T. Maekawa, D.S. Kumar

Research output: Contribution to journalArticlepeer-review


Polysaccharides that show finest bioactivities and physicochemical properties are always promising for bionanoscience applications. Mauran is such a macromolecule extracted from halophilic bacterium, Halomonas maura for biotechnology and nanoscience applications. Antioxidant properties of MR/CH nanoparticles were studied using biochemical assays to prove the versatility of these test nanoparticles for biomedical applications. Here, we demonstrate the prospects of extremophilic polysaccharide, mauran based nanoparticles for scavenging reactive oxygen species in both in vitro and ex vivo conditions. 5-fluorouracil loaded MR/CH nanoparticles were tested for anticancer proliferation and compared their therapeutic efficiency using breast adenocarcinoma and glioma cells. Fluorescently labeled nanoparticles were employed to show the cellular uptake of these nanocarriers using confocal microscopic imaging and flow cytometry.
Original languageEnglish
Pages (from-to)310-319
JournalInternational Journal of Biological Macromolecules
Publication statusPublished - 6 Mar 2015


Dive into the research topics of 'Extremophilic polysaccharide nanoparticles for cancer nanotherapy and evaluation of antioxidant properties'. Together they form a unique fingerprint.

Cite this